Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$2,656,001
-70.18%
Shares
Shares Volume: 98,334 Shares
Average Share Price: $27.01
INSIDER
White William Richard
Chief Financial Officer (Officer)
reported on Aug 29 2024
traded on Aug 26 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 41,791 |
| PURCHASES/SALES 1Y | 0 / 7 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $1,168,830.56 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 2 / 39 |
| P/S VALUE RATIO | 0.213 |
| AVERAGE SALE VALUE | $442,726.66 |
| COMPANY PREVIOUS TRADES |